Plasma therapy no longer part of Covid 19 treatment says ICMR
We Care...!!!

NEW DELHI: The authorities on Monday dropped the usage of convalescent plasma therapy for treating Covid sufferers from Clinical Management Guidelines.
Last week, the ICMR-National Task Force for Covid-19 held a gathering wherein all of the members have been in favour of eradicating the usage of convalescent plasma from the rules, citing its ineffectiveness and inappropriate use in a number of instances.
An Indian Council of Medical Research (ICMR) official stated the duty pressure “revised” the Clinical Guidance for Management of Adult Covid-19 Patients and “dropped convalescent plasma (off label)”.
The determination to take away it from the rules comes within the backdrop of some clinicians and scientists writing to Principal Scientific Advisor Ok VijayRaghavan cautioning in opposition to the “irrational and non-scientific use” of convalescent plasma for Covid-19 within the nation.
In the letter, which was additionally marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public well being professionals alleged that the present tips on plasma remedy aren’t primarily based on current proof and identified some very early proof that signifies a doable affiliation between emergence of variants with “decrease susceptibility to neutralising antibodies in immunosuppressed” individuals given plasma remedy.
This raises the opportunity of extra virulent strains creating on account of irrational use of plasma remedy which might gasoline the pandemic, based on the letter signed by vaccinologist Gagandeep Kang, surgeon Pramesh C S and others.
“We are writing to you as involved clinicians, public well being professionals and scientists from India concerning the irrational and non- scientific use of convalescent plasma for Covid-19 within the nation.
“This has stemmed from tips issued by authorities businesses, and we request your pressing intervention to deal with the difficulty which might forestall harassment of Covid-19 sufferers, their households, their clinicians and Covid-19 survivors,” stated the letter.
“The present analysis proof unanimously signifies that there isn’t any profit provided by convalescent plasma for therapy of Covid-19. However, it continues to be prescribed rampantly in hospitals throughout India,” the letter stated.
(With company inputs)


Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »